Related Experiment Video
Updated: Jun 4, 2026
05:52
Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
Published on: November 4, 2021
An overview of embolic agents
Sandeep Vaidya1, Kathleen R Tozer, Jarvis Chen
1Department of Radiology, University of Washington, Seattle, Washington.
Seminars in Interventional Radiology
|February 18, 2011
Summary
This review covers therapeutic embolization agents used in interventional radiology. It guides selection, use, and limitations of these embolic materials.
Area of Science:
- Interventional Radiology
- Vascular Interventions
Background:
- Therapeutic embolization is a cornerstone procedure in interventional radiology.
- A diverse array of embolic agents is currently available for clinical use.
Purpose of the Study:
- To provide a concise overview of currently available therapeutic embolization agents.
- To offer guidance on the appropriate selection of embolic agents based on clinical scenarios.
- To enhance reader familiarity with the proper application and inherent limitations of various agents.
Main Methods:
- Literature review of therapeutic embolization agents.
- Analysis of agent properties, indications, and contraindications.
- Synthesis of information for practical clinical guidance.
Main Results:
- Detailed description of various embolic agents, including established and novel options.
- Comparative analysis highlighting the unique characteristics and applications of each agent.
- Discussion of factors influencing agent selection, such as lesion type, anatomy, and desired outcome.
Conclusions:
- Appropriate selection and utilization of therapeutic embolization agents are crucial for successful interventional radiology procedures.
- Understanding the specific properties and limitations of each agent optimizes treatment efficacy and patient safety.
- This review serves as a practical guide for clinicians navigating the evolving landscape of embolic materials.
Related Concept Videos
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...